沃特世收购Halo Labs，扩展生物分析产品组合-动脉网

Waters Acquires Halo Labs, Expanding Biological Analysis Portfolio

CISION 等信源发布 2025-05-21 20:10



可切换为仅中文







MILFORD, Mass.

马萨诸塞州米尔福德

，

May 21, 2025

2025年5月21日

/PRNewswire/ -- Waters Corporation (NYSE:

/PRNewswire/ -- 沃特世公司 (纽约证券交易所：

WAT

) today announced that it has acquired Halo Labs™, an innovator of specialized imaging technologies to detect, identify, and count interfering materials (particles) in therapeutic products, such as cell, protein, and gene therapies.

）今天宣布收购了Halo Labs™，这是一家专注于成像技术的创新公司，致力于检测、识别和计数治疗产品（如细胞、蛋白质和基因疗法）中的干扰物质（颗粒）。

The Aura™ platform from Halo Labs features a highly differentiated technology that performs full spectrum particle analysis and is complementary to the Waters light scattering detection solutions from its Wyatt Technology™ Portfolio. For example, its subvisible particle technology unlocks additional insights when characterizing external particles used to amplify CAR T-cells for cell therapy, detecting these translucent process impurities that are currently undetectable by standard methods.

Halo Labs的Aura™平台采用了一种高度差异化的技术，可进行全光谱颗粒分析，是对Waters光散射检测解决方案（来自其Wyatt Technology™产品组合）的有力补充。例如，其亚可见颗粒技术在表征用于扩增CAR T细胞的外部颗粒时，能够提供额外的见解，检测出目前标准方法无法检测到的半透明工艺杂质。

By acquiring this innovative company, Waters will be able to integrate this emerging technology into new and existing large molecule development and QA/QC, giving a key value-add to customers while accelerating the Company's growth into analytical and bioprocessing testing for large molecule therapies..

通过收购这家创新公司，沃特世将能够将这种新兴技术融入到新的和现有的大分子开发和质量保证/质量控制中，为客户带来重要的附加价值，同时加速公司在大分子治疗领域的分析和生物处理测试方面的增长。

'Adding the innovative low-sample-volume, high-throughput technology from Halo Labs provides analysis for a broad range of sample types and volumes, enabling earlier insights during therapy development and greater safety during manufacturing,' said Dr.

“Halo Labs 提供的创新低样本量、高通量技术能够分析各种类型的样本和体积，从而在治疗开发过程中提供更早的洞察，并在生产过程中提高安全性，”博士说道。

Udit Batra

乌迪特·巴特拉

, President and Chief Executive Officer, Waters Corporation. 'With the rapid growth of treatments like CAR T-cell therapies, we are investing in the innovation our customers need. Together with our existing Wyatt Technology product lines, this acquisition enhances our leadership position in specialized analytical technologies for emerging biopharma therapies.'.

沃特世公司总裁兼首席执行官。“随着CAR-T细胞疗法等治疗手段的快速发展，我们正在投资客户所需的创新。结合我们现有的怀亚特科技产品线，此次收购进一步巩固了我们在新兴生物制药疗法专用分析技术领域的领导地位。”

'We are thrilled to join forces with Waters, a company that shares our values of purposeful innovation and customer focus,' said

“我们很高兴与沃特世公司携手合作，这是一家与我们同样重视有意义的创新和以客户为中心的公司，”

Rick Gordon

里克·戈登

, Chief Executive Officer, Halo Labs. 'This combination accelerates our vision to expand our platform's reach, enhancing therapeutic development and production while maintaining our unwavering commitment to drug quality and safety. We look forward to driving more groundbreaking advancements that benefit patients worldwide.'.

，首席执行官，Halo Labs。 “这一组合加速了我们扩展平台覆盖范围的愿景，加强治疗开发和生产，同时恪守我们对药品质量和安全的坚定承诺。我们期待推动更多突破性进展，造福全球患者。”

Today's acquisition of Halo Labs is expected to have a negligible impact on the Company's income statement over the following 12 months.

预计今天对Halo Labs的收购将在未来12个月内对公司损益表产生微乎其微的影响。

About Halo Labs

关于光环实验室

Halo Labs

光环实验室

is a venture-backed scientific instrumentation and consumable company that commercializes high throughput biopharmaceutical formulation, stability, and product quality control tools for aggregate and subvisible particle analysis using state-of-the-art custom optics and image processing techniques. Biopharmaceutical companies around the globe depend on Halo Labs for unprecedented insights into their drug products..

是一家由风险投资支持的科学仪器和耗材公司，致力于将高通量生物制药配方、稳定性及产品质量控制工具商业化，用于聚集体和亚可见颗粒分析，采用最先进的定制光学和图像处理技术。全球的生物制药公司依赖Halo Labs获取对其药物产品的前所未有的洞察。

About Waters Corporation

关于沃特世公司

Waters Corporation

沃特世公司

(NYSE:

（纽约证券交易所：

WAT

), is a global leader in analytical instruments, separations technologies, and software, serving the life, materials, food, and environmental sciences for over 65 years. Our Company helps ensure the efficacy of medicines, the safety of food and the purity of water, and the quality and sustainability of products used every day.

），是一家全球领先的分析仪器、分离技术及软件供应商，为生命科学、材料科学、食品科学和环境科学领域服务了65年以上。我们公司帮助确保药品的有效性、食品的安全性、水的纯净度，以及日常使用产品的质量和可持续性。

In over 100 countries, our 7,600+ passionate employees collaborate with customers in laboratories, manufacturing sites, and hospitals to accelerate the benefits of pioneering science..

在 100 多个国家/地区，我们 7600 多名充满热情的员工与实验室、制造基地和医院的客户通力合作，加速开创性科学带来的益处。

Halo Labs, Aura, and Wyatt Technology are trademarks of Waters Technologies Corporation.

Halo Labs、Aura 和 Wyatt Technology 是 Waters Technologies Corporation 的商标。

Contact:

联系人：

Laura Borland

劳拉·博兰

Senior Director, Business Unit Communications

高级总监，业务部门传播

Waters Corporation

沃特世公司

laura_borland@waters.com